Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Generation of Orthotopic Patient-Derived Xenograft in Humanized Mice for Evaluation of Emerging Targeted Therapies and Immunotherapy Combinations for Melanoma

Preprints.org(2023)10.20944/preprints202307.0566.v1Source: DataRank Database

Generation of Orthotopic Patient-Derived Xenograft in Humanized Mice for Evaluation of Emerging Targeted Therapies and Immunotherapy Combinations for Melanoma is a research paper published in Preprints.org (2023). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: greenTopics (20)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Caroline A. Nebhan ORCID,Nabil Saleh ORCID,Rebecca L. Shattuck-Brandt ORCID,Sheau‐Chiann Chen ORCID,Gregory D. Ayers ORCID

Live enrichment

PubMed:26207759 OpenAlex:https://openalex.org/W4383740867

National Institutes of Health

Grant: 1S10OD023475-01A1

Leica Bond RX

National Institutes of Health

Grant: 3P30CA016058-15S1

CORE--HORMONE RECEPTOR LABORATORY

National Institutes of Health

Grant: 3P30CA068485-23S2

Cancer Center Support Grant

National Institutes of Health

Grant: 5IK6BX005225-04

BLR&D Merit Review Research Career Scientist (RCS) Award (IK6)

National Institutes of Health

Grant: 5R37CA233770-04

Combining senescence-inducing and senolytic agents to improve melanoma therapy

National Institutes of Health

Grant: 5R01CA116021-09

Impact of IKKB and AurK Inhibitors on Host Immunity and Melanoma

greenLicense: cc-by

repositoryhttps://www.preprints.org/manuscript/202307.0566/v1/download

repositoryhttps://doi.org/10.20944/preprints202307.0566.v1

https://doi.org/10.3390/cancers15143695

https://pubmed.ncbi.nlm.nih.gov/37509357

Fields of Study

Virus-based gene therapy researchCAR-T cell therapy researchImmunotherapy and Immune Responses03 medical and health sciences0302 clinical medicine

Keywords

Humanized mouseMedicineImmune systemMelanomaCD8ImmunotherapyCancer researchImmunologyBystander effectpatient-derived xenografthumanized miceOncology and OncogenicsMedicine and Pharmacologytargeted therapyArticle